Analyst Color - Spark Newswire

1 minute read

Why This Hims Analyst Sees Strong Growth Potential In Highly Competitive Market

Today, 12:04 PM

The potential for expansion coupled with a highly competitive pharmacy market has a BofA Securities analyst sidelined on shares of Hims & Hers Health, Inc. (NYSE: HIMS).

HIMS

1 minute read

American Express Gets Upgrade, ‘Meaningful Upside’ Says Goldman Sachs Analyst

By Priya Nigam

Today, 12:04 PM

While American Express Company (NYSE: AXP) projects reaching its original goals set for 2020 in 2022, the company seems well-positioned to exceed these expectations, according to Goldman Sachs.

AXP

2 minute read

Why This Apple Stock Analyst Says It’s Time To Buy

By Shanthi Rexaline

Today, 12:04 PM

After a not-so-enterprising first-half, Apple, Inc.

AAPL

1 minute read

BofA Raises XPeng Target On P7, G3i, P5 Prospects

By Priya Nigam

Today, 12:04 PM

While Xpeng Inc - ADR (NYSE: XPEV) is facing strong demand for P7, the G3i launch scheduled for Friday could be the next catalyst, according to BofA Securities.

XPEV

1 minute read

Nio Expected To Gross 5% More EV Deliveries In 2021 Than Previous Forecast, Says CICC

By Rachit Vats

Today, 12:04 PM

China International Capital Corporation Limited has updated its forecast for Nio Inc (NYSE: NIO), saying it expects the Chinese electric vehicle maker to sell 98,000 cars in 2021, 5% more than its previous estimate, as per a cnEVpost

2 minute read

Why The Tight US Labor Market May Be Here To Stay

By Wayne Duggan

Today, 12:04 PM

In a series of blog posts last week, Commonwealth Financial Network chief investment officer Brad McMillan discussed just what’s going on with labor shortages in the U.S. economy.

SPY

2 minute read

Tesla Q2 Deliveries Evidence of ‘True Growth Story,’ EV Maker On Track to Exceed 2021 Deliveries Forecast: Gene Munster

By Shanthi Rexaline

Today, 12:04 PM

Tesla, Inc. (NASDAQ: TSLA)

1 minute read

Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter

By Nikhil Dayal

Today, 12:04 PM

A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASDAQ: ITRM) failed to deter H.C. Wainwright & Co’s bullish sentiment on Iterum stock.

ITRM

1 minute read

Why A 5-Ship Deal Is Reinforcing This Danaos Analyst’s Bull Case

By Nikhil Dayal

Today, 12:04 PM

A deal involving the acquisition of five ships has furthered a Jefferies analyst's bullish sentiment on Danaos Corp. (NYSE: DAC).

DAC

2 minute read

Why The DiDi IPO Is Good News For Uber: BofA

By Shanthi Rexaline

Today, 12:04 PM

Following Chinese ride-hailing giant DiDi Global Inc.'s (NYSE: DIDI) Wall Street debut, an analyst at BofA Securities reiterated a bullish take on U.S.

DASH